Literature DB >> 33026692

Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study.

Andrea Garcia-Guillen1, Sarah Stewart2, Isabel Su2, William J Taylor3, Angelo L Gaffo4, Merryn Gott2, Julia Slark2, Anne Horne2, Nicola Dalbeth2.   

Abstract

OBJECTIVE: The patient experience of a gout flare is multidimensional. To establish the most appropriate methods of flare measurement, there is a need to understand the complete experience of a flare. This qualitative study aimed to examine what factors contribute to the severity of a flare from the patient perspective.
METHODS: Face-to-face interviews were conducted with patients with gout. Participants were asked to share their experience with their worst gout flare and contrast it to their experience of a less severe or mild flare. Interviews were audio recorded and transcribed verbatim. Data were analyzed using a reflexive thematic approach.
RESULTS: In total, 22 participants with gout (17 male participants, mean age 66.5 years) were interviewed at an academic center in Auckland, New Zealand. Four key themes were identified as contributing to the severity of a flare: 1) flare characteristics (pain intensity, joint swelling, redness and warmth, duration, and location); 2) impact on function (including walking, activities of daily living, wearing footwear, and sleep); 3) impact on family and social life (dependency on others, social connection, and work); and 4) psychological impact (depression, anxiety, irritability, and sense of control).
CONCLUSION: A wide range of interconnecting factors contribute to the severity of a gout flare from the patient perspective. Capturing these domains in long-term gout studies would provide a more meaningful and accurate representation of cumulative flare burden.
© 2020, American College of Rheumatology.

Entities:  

Mesh:

Year:  2022        PMID: 33026692     DOI: 10.1002/acr.24475

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  3 in total

1.  12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.

Authors:  Till Uhlig; Lars F Karoliussen; Joseph Sexton; Tove Borgen; Espen A Haavardsholm; Tore K Kvien; Hilde Berner Hammer
Journal:  RMD Open       Date:  2021-03

2.  The illness perception and health promotion behaviour of young and middle-aged patients with hyperuricaemia: A qualitative study.

Authors:  Li Liu; Hong-Hong Jia; Yu-Qiu Zhou; Yan-Rui Liu; Fei Yin; Xiu-Fang Liu
Journal:  Nurs Open       Date:  2022-01-28

3.  Onset of depression and anxiety among patients with gout after diagnosis: a population-based incident cohort study.

Authors:  Alyssa Howren; Eric C Sayre; Hyon K Choi; J Antonio Avina-Zubieta; Kam Shojania; Jamie Y Park; Mary A De Vera
Journal:  BMC Rheumatol       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.